NCCN Guidelines Insights: Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Authors:
  • WWWilliam G. Wierda
    William G. Wierda
  • JBJohn C. Byrd
    John C. Byrd
  • JAJeremy S. Abramson
    Jeremy S. Abramson
  • SBSyed F. Bilgrami
    Syed F. Bilgrami
  • GBGreg Bociek
    Greg Bociek
  • DBDanielle Brander
    Danielle Brander
  • JBJennifer Brown
    Jennifer Brown
  • ACAsher A. Chanan-Khan
    Asher A. Chanan-Khan
  • JCJulio C. Chavez
    Julio C. Chavez
  • SCSteve E. Coutre
    Steve E. Coutre
  • RDRandall S. Davis
    Randall S. Davis
  • CFChristopher D. Fletcher
    Christopher D. Fletcher

Abstract
Chronic lymphocytic leukemia (CLL) is generally characterized by an indolent disease course. Histologic transformation (also known as Richter's transformation) to more aggressive lymphomas, such as diffuse large B-cell lymphoma or Hodgkin lymphoma, occurs in approximately 2% to 10% of patients and is associated with a poor prognosis. These NCCN Guidelines Insights discuss the recommendations for the diagnosis and management of patients with histologic transformation.

This publication has 31 references indexed in Scilit: